2020 Virtual Summit
1 2 3
News & Information
New Treatments and Clinical Trials: The Use of Genetic Information to Attack Cancers

Dr. Keith Crawford, PHEN Director of Clinical Trials and Patient Education
Genetic Testing Can Impact Your Prostate Cancer Journey

Todd Cohen, MD, Vice President of Medical Affairs and Medical Director of Urology at Myriad Genetics
Why African American Prostate Cancer Is a Crisis Within the COVID-19 Crisis
By: Thomas A. Farrington, PHEN President and Founder
featured in June issue of "Future of Personal Health" as part of the "Prostate and Urological Health Campaign."
Celebrating 20 Years of Prostate Cancer Survivorship on July 4th, 2020

On July 4th, 2000 my wife Juarez and I boarded a plane in Boston, MA, launching our prostate cancer journey and changing our lives forever. My father's life was taken by prostate cancer on Christmas Eve 1999 at age 78. Three months later...

PSA Screening for Prostate Cancer More Beneficial Than Previously Recognized PSA Screening for Prostate Cancer More Beneficial Than Previously Recognized
By: Jody A. Chernow; Renal and Urology News; June 25, 2020
Inherited mutation linked to higher prostate cancer risk in African American families Inherited mutation linked to higher prostate cancer risk in African American families

A new study identifies an inherited genetic variant associated with higher risk of prostate  in men of African descent.
Partners